Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function

Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function

US Patent 10525057 · Granted Jan 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 en2022
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 en2022
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 en2021
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 en2021
Once daily formulations of tetracyclines2014
Once daily formulations of tetracyclines2013
Once daily formulations of tetracyclines2013
Once daily formulations of tetracyclines2013
Once daily formulations of tetracyclines2012
Once daily dosage forms of trospium2010
Trospium chloride treatment method2010
Once daily dosage forms of trospium2010